On November 1, 2022 Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, reported that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022 (Press release, Quest Diagnostics, NOV 1, 2022, View Source,-Joins-Board-of-Directors [SID1234622706]). In addition, Mr. Davis has been elected to the company’s Board of Directors, expanding the board from nine to 10 directors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mr. Rusckowski, who has served as CEO and President since May 2012, remains Chairman of the company’s Board of Directors through March 2023.
"It is an honor to lead this great company that is committed to making this a healthier world," said Mr. Davis. "Our team will remain laser-focused on growing this business, driving operational excellence, and continuing to invest in important growth opportunities, including advanced diagnostics and consumer initiated testing, as we provide patients and customers with important insights that can improve health outcomes."
Mr. Davis continued: "On behalf of our 50,000 colleagues, I would like to thank Steve for his decade of leadership, placing Quest at the forefront of healthcare. We will build upon the foundation he has established."
Biographical information on Jim Davis
Mr. Davis joined Quest Diagnostics in 2013 as Senior Vice President, Diagnostics Solutions. Over the last two and a half years he has led the company’s operational response to the COVID-19 pandemic. Before joining Quest, he served as CEO of InSightec, Inc., a medical device company. Prior to that, Jim held senior management positions in a two-decade career in General Electric’s aviation and healthcare businesses, including leading GE’s MRI business for five years. Before GE, Mr. Davis led the development of strategic and operating initiatives for clients of McKinsey & Company, Inc. Mr. Davis holds a master’s degree in management from the Sloan School of Management at Massachusetts Institute of Technology, a master’s degree in science from MIT and a bachelor’s degree in aeronautical engineering from the University of Michigan.